Endowment Wealth Management, Inc.

Endowment

Position in HUMA — Humacyte, Inc.

CIK 1904477 APPLETON, WI

Position in HUMA

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$82,226

+$18,238 QoQ

Shares Held

105,418

0.0% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#51

of 161 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

Endowment Wealth Management, Inc. holds $369,618 across 4 Biotechnology names. HUMA ranks #2 (22.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	4,793	$225,462
2	HUMA	Humacyte, Inc. This page	105,418	$82,226
3	RXRX	Recursion Pharmaceuticals, Inc.	12,480	$45,801
4	CHRS	Coherus Oncology, Inc.	11,521	$16,129

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$82,226	105,418	0.0%	Shares	Sole	2026-08-06
2026-03-31	$63,988	105,418	-0.5%	Shares	Sole	2026-05-08
2025-12-31	$101,782	105,913	-3.2%	Shares	Sole	2026-02-09
2025-09-30	$190,456	109,458	0.0%	Shares	Sole	2025-11-06
2025-06-30	$228,767	109,458	+5.1%	Shares	Sole	2025-07-25
2025-03-31	$177,504	104,108	0.0%	Shares	Sole	2025-05-09
2024-12-31	$525,745	104,108	+3.6%	Shares	Sole	2025-02-07
2024-09-30	$546,817	100,518	0.0%	Shares	Sole	2024-11-06
2024-06-30	$482,486	100,518	+3.1%	Shares	Sole	2024-08-01
2024-03-31	$303,280	97,518	0.0%	Shares	Sole	2024-05-08
2023-12-31	$276,951	97,518	0.0%	Shares	Sole	2024-02-07
2023-09-30	$285,727	97,518	0.0%	Shares	Sole	2023-10-31
2023-06-30	$278,901	97,518	+0.9%	Shares	Sole	2023-08-10
2023-03-31	$298,549	96,618	0.0%	Shares	Sole	2023-05-10
2022-12-31	$203,863	96,618	0.0%	Shares	Sole	2023-02-13
2022-09-30	$314,974	96,618	0.0%	Shares	Sole	2022-11-14
2022-06-30	$310,143	96,618	0.0%	Shares	Sole	2022-08-15
2022-03-31	$682,123	96,618	0.0%	Shares	Sole	2022-05-04
2021-12-31	$700,480	96,618	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.